Clinical trial
Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal…
NCT00051480 · GenVec, Industry · Completed
Key facts
| NCT number | NCT00051480 |
|---|---|
| Title | Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer |
| Official title | A Single Arm, Phase II Study of TNFerade™ Biologic Gene Therapy + Radiation + 5-FU and Cisplatin in Locally Advanced, Resectable, Esophageal Cancer |
| Lead sponsor | GenVec, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Genetic |
| Interventions | TNFerade |
| First posted | Jan 13, 2003 |
| Last update posted | May 12, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: